Smithbridge Asset Management Inc. DE purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 22,068 shares of the healthcare conglomerate's stock, valued at approximately $11,558,000. UnitedHealth Group makes up 2.1% of Smithbridge Asset Management Inc. DE's investment portfolio, making the stock its 9th largest holding.
A number of other large investors have also made changes to their positions in the stock. NewSquare Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $26,000. Hurley Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at approximately $32,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.
UnitedHealth Group Stock Performance
Shares of UNH stock traded down $5.11 during mid-day trading on Friday, hitting $313.39. 13,729,200 shares of the stock were exchanged, compared to its average volume of 7,185,784. The stock's fifty day simple moving average is $391.47 and its two-hundred day simple moving average is $476.22. The stock has a market capitalization of $284.28 billion, a price-to-earnings ratio of 20.22, a P/E/G ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion for the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period in the previous year, the business posted $6.91 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.
UnitedHealth Group Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.82%. UnitedHealth Group's dividend payout ratio is 37.02%.
Wall Street Analyst Weigh In
UNH has been the topic of a number of research reports. TD Cowen cut UnitedHealth Group from a "buy" rating to a "hold" rating and set a $308.00 price target on the stock. in a research note on Monday, May 19th. Piper Sandler decreased their price target on UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating on the stock in a research note on Tuesday, June 3rd. Baird R W cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday. Morgan Stanley decreased their price target on UnitedHealth Group from $563.00 to $374.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $426.52.
Check Out Our Latest Stock Analysis on UNH
Insider Transactions at UnitedHealth Group
In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,533 shares of the firm's stock in a transaction dated Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares of the company's stock, valued at approximately $1,935,386.40. This represents a 34.07% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John H. Noseworthy bought 300 shares of the firm's stock in a transaction dated Wednesday, May 14th. The shares were acquired at an average price of $312.16 per share, with a total value of $93,648.00. Following the purchase, the director now directly owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders acquired 109,408 shares of company stock worth $31,607,768. Company insiders own 0.28% of the company's stock.
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.